NCT02075528View on ClinicalTrials.gov

Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

May 31, 2012

Study Completion Date

July 31, 2012

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Paliperidone ER

9 mg/d of paliperidone ER was administered during the first 2 weeks, after which the dose was adjusted clinically

Trial Locations (1)

110

Taipei City Hospital, Songde Branch, Taipei

Sponsors
All Listed Sponsors
collaborator

Johnson & Johnson Taiwan Ltd

INDUSTRY

collaborator

Taipei Institute of Pathology

OTHER_GOV

lead

Taipei City Hospital

OTHER_GOV